Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Roche Holding AG

Revenue

Price Targets

# of Analysts

Consensus Recommendation

EBITDA

EBIT

Free Cash Flow

FFO / Share

AFFO / Share

NAV / Share

Book Value / Share

CapEx

Estimates	Dec '23 (A)	Dec '24 (A)	Dec '25 (E)
Mean	CHF 22,764.71	CHF 23,173.39	CHF 24,575.99
Median	CHF 22,737.83	CHF 23,123.70	CHF 24,717.75
Actual	CHF 21,976.00	CHF 23,538.00	—
High	CHF 24,454.00	CHF 25,915.12	CHF 26,466.32
Low	CHF 21,759.04	CHF 19,815.48	CHF 22,646.00
Standard Deviation	CHF 658.85	CHF 1,476.40	CHF 1,078.29
# of Estimates	14	13	13